State Street Corp Jounce Therapeutics, Inc. Transaction History

State Street Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.9 - $1.85 $143,220 - $294,397	159,134 Added 24.55%	807,443 $1.49 Million
Q4 2022 Feb 14, 2023	SELL	$0.64 - $1.99 $3,024 - $9,404	-4,726 Reduced 0.72%	648,309 $719,000
Q3 2022 Nov 15, 2022	SELL	$2.73 - $4.92 $13,333 - $24,029	-4,884 Reduced 0.74%	653,035 $1.53 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $7.67 $355,292 - $973,246	126,890 Added 23.9%	657,919 $1.99 Million
Q1 2022 May 16, 2022	BUY	$6.01 - $8.54 $145,868 - $207,274	24,271 Added 4.79%	531,029 $3.61 Million
Q4 2021 Feb 14, 2022	BUY	$7.11 - $9.64 $62,376 - $84,571	8,773 Added 1.76%	506,758 $4.23 Million
Q3 2021 Nov 15, 2021	BUY	$5.04 - $8.73 $298,468 - $516,990	59,220 Added 13.5%	497,985 $3.7 Million
Q2 2021 Aug 16, 2021	BUY	$6.58 - $10.66 $871,757 - $1.41 Million	132,486 Added 43.26%	438,765 $2.98 Million
Q1 2021 May 17, 2021	SELL	$6.73 - $13.87 $150,933 - $311,062	-22,427 Reduced 6.82%	306,279 $3.15 Million
Q4 2020 Feb 16, 2021	SELL	$6.37 - $10.33 $43,570 - $70,657	-6,840 Reduced 2.04%	328,706 $2.3 Million
Q3 2020 Nov 10, 2020	SELL	$4.58 - $10.95 $92,378 - $220,861	-20,170 Reduced 5.67%	335,546 $2.74 Million
Q2 2020 Aug 14, 2020	SELL	$4.17 - $7.58 $262,943 - $477,964	-63,056 Reduced 15.06%	355,716 $2.45 Million
Q1 2020 May 11, 2020	BUY	$2.91 - $8.7 $1.22 Million - $3.64 Million	418,772 New	418,772 $1.99 Million

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.